COL1A1 and heart failure: A multi-level transcriptomics (mRNA, lncRNA, miRNA) sequencing of left ventricular samples from patients with end-stage heart failure identified COL1A1 as a biomarker for the prognosis of heart failure, and it was also verified at the plasma level [33].